Page last updated: 23 September, 2021, 11:31am Musculoskeletal and joint diseases Upadacitinib for treating severe rheumatiod arthritis NICE TA665 position statementDownload Filgotinib for treating moderate to severe rheumatoid arthritis (NICE TA676) position statementDownload Glucosamine MSEMOC Position statementDownload Rubefacients MSEMOC Position statementDownload